{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:28:27Z","timestamp":1790364507518,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>Sugammadex is a novel agent for the reversal of neuromuscular blockade. The speed and efficacy of reversal with sugammadex are significantly faster than acetylcholinesterase inhibitors, such as neostigmine. Sugammadex also has a limited adverse profile when compared with acetylcholinesterase inhibitors, specifically in regard to the incidence of bradycardia. This adverse effect may be particularly relevant in the setting of a heart transplant recipient with a denervated heart. The authors present a case of an 8-year-old child, status postcardiac transplantation, who required anesthetic care for laparoscopy and lysis of intra-abdominal adhesions. Sugammadex was used to reverse neuromuscular blockade and avoid the potential adverse effects of neostigmine. The unique mechanism of action of sugammadex is discussed, previous reports of its use in this unique patient population are reviewed, and its potential benefits compared to traditional acetylcholinesterase inhibitors are presented.<\/jats:p>","DOI":"10.4103\/aca.aca_15_17","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T05:07:37Z","timestamp":1499836057000},"page":"376-378","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation"],"prefix":"10.4103","volume":"20","author":[{"given":"Karen","family":"Miller","sequence":"first","affiliation":[{"name":"The Ohio State University College of Medicine, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D","family":"Tobias","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA"},{"name":"Department of Anesthesiology and Pain Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250920","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/pan.13050","article-title":"Current evidence for the use of sugammadex in children","volume":"27","author":"Tobias","year":"2017","journal-title":"Paediatr Anaesth"},{"key":"R2-20250920","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcrc.2008.10.010","article-title":"Preclinical pharmacology of sugammadex","volume":"24","author":"Bom","year":"2009","journal-title":"J Crit Care"},{"key":"R3-20250920","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1213\/01.ane.0000244594.63318.fc","article-title":"Sugammadex: Another milestone in clinical neuromuscular pharmacology","volume":"104","author":"Naguib","year":"2007","journal-title":"Anesth Analg"},{"key":"R4-20250920","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3565(25)38120-6","article-title":"Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine","volume":"265","author":"Backman","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"R5-20250920","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/bja\/49.3.265","article-title":"Anaesthesia for major surgery in a patient with a transplanted heart","volume":"49","author":"Samuels","year":"1977","journal-title":"Br J Anaesth"},{"key":"R6-20250920","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/0019-5049.93356","article-title":"Anaesthesia for non-cardiac surgery in a cardiac transplant recipient","volume":"56","author":"G\u00f3mez-R\u00edos","year":"2012","journal-title":"Indian J Anaesth"},{"key":"R7-20250920","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00000542-199304000-00021","article-title":"Neostigmine produces bradycardia in a heart transplant patient","volume":"78","author":"Backman","year":"1993","journal-title":"Anesthesiology"},{"key":"R8-20250920","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF03011717","article-title":"Neostigmine decreases heart rate in heart transplant patients","volume":"43","author":"Backman","year":"1996","journal-title":"Can J Anaesth"},{"key":"R9-20250920","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1213\/00000539-199404000-00029","article-title":"Sinus arrest after intravenous neostigmine in two heart transplant recipients","volume":"78","author":"Beebe","year":"1994","journal-title":"Anesth Analg"},{"key":"R10-20250920","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/j.jvca.2012.09.009","article-title":"Cardiac arrest and neuromuscular blockade reversal agents in the transplanted heart","volume":"27","author":"Bertolizio","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R11-20250920","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF03019764","article-title":"Asystole after intravenous neostigmine in a heart transplant recipient","volume":"48","author":"Bjerke","year":"2001","journal-title":"Can J Anaesth"},{"key":"R12-20250920","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.anes.0000282140.68060.fa","article-title":"Cardiac arrest after neuromuscular blockade reversal in a heart transplant infant","volume":"107","author":"Sawasdiwipachai","year":"2007","journal-title":"Anesthesiology"},{"key":"R13-20250920","first-page":"903","article-title":"Use of combination of rocuronium and sugammadex in heart transplant recipients","volume":"40","author":"G\u00f3mez-R\u00edos","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"R14-20250920","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1053\/j.jvca.2016.02.012","article-title":"Safety of sugammadex for neuromuscular reversal in cardiac transplant patients","volume":"30","author":"Varela","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R15-20250920","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.jvca.2015.06.009","article-title":"Use of sugammadex in a heart transplant recipient: Review of the unique physiology of the transplanted heart","volume":"30","author":"Tezcan","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R16-20250920","first-page":"160","article-title":"Anesthetic management for endoscopic sinus surgery in a patient with transplanted heart \u2013 A case report","volume":"64","author":"Hashimoto","year":"2015","journal-title":"Masui"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00660469-201720030-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:47:59Z","timestamp":1787838479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00660469-201720030-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_15_17","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}